However, Soren Lontoft, pharma equity analyst at Sydbank, told CNBC last week that there was need for a diverse range of treatments to address both obesity and tolerability levels, as well as associated health risks like cardiovascular disease, sleep apnea and liver disease
The difference is real but not dramaticboth produce substantial weight loss
Certain genetic variants, carried by around 10 percent of the population, could be making type 2 diabetes GLP-1 treatments (such as Ozempic and Wegovy) less effective, according to new research
Heather Liked by Brandon Owen Great time connecting with colleagues at the Orthopreneurs Summit in Austin
Both are used for diabetes management
GLP-1 drugs suppress appetite hard, which crashes both calorie intake and protein intake at the same time